Sanofi/Regeneron Announce Encouraging Dupilumab Data World News Network, 10 Jul 2014 Sanofi (SNY) and partner Regeneron Pharmaceuticals, Inc. (REGN) announced positive results from a phase IIb study (n=380) on…